From the Departments of *Epidemiology, †Global Health, and ‡Medicine, University of Washington, Seattle, WA
Conflicts of interest: L.E.M. has received study drugs from Pfizer, Inc and conference support from Bio-Rad. R.S.M. has received speaking and consultancy fees from Embil Pharmaceutical Company and research funding from Gen-Probe/Hologic.
Correspondence: Lisa E. Manhart, PhD, UW Center for AIDS and STD, 325 9th Ave, Seattle, WA 98104. E-mail: email@example.com.
Received for publication February 15, 2013, and accepted March 14, 2013.